Myriad Genetics Inc MYGN
$4.27
+2.40%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | FORM 4 | 2026-09-22 | View → |
| 4 | FORM 4 | 2026-09-18 | View → |
| 4 | FORM 4 | 2026-09-17 | View → |
| 8-K | 8-K | 2026-09-16 | View → |
| 4 | FORM 4 | 2026-09-08 | View → |
| 4 | FORM 4 | 2026-08-17 | View → |
| 10-Q | 10-Q | 2026-07-31 | View → |
| 8-K | 8-K | 2026-07-30 | View → |
| 4 | FORM 4 | 2026-06-23 | View → |
| 8-K | 8-K | 2026-06-23 | View → |
| 4 | FORM 4 | 2026-06-12 | View → |
| 4 | FORM 4 | 2026-06-12 | View → |
| 4 | FORM 4 | 2026-06-09 | View → |
| 4 | FORM 4 | 2026-06-05 | View → |
| 4 | FORM 4 | 2026-06-05 | View → |
| 4 | FORM 4 | 2026-06-05 | View → |
| 4 | FORM 4 | 2026-06-05 | View → |
| 4 | FORM 4 | 2026-06-05 | View → |
| 4 | FORM 4 | 2026-06-05 | View → |
| 4 | FORM 4 | 2026-06-05 | View → |
| 4 | FORM 4 | 2026-06-05 | View → |
| 8-K | 8-K | 2026-06-04 | View → |
| 4 | FORM 4 | 2026-06-02 | View → |
| 4 | FORM 4 | 2026-05-14 | View → |
| 10-Q | 10-Q | 2026-05-06 | View → |
| 8-K | 8-K | 2026-05-05 | View → |
| 4 | FORM 4 | 2026-05-04 | View → |
| 4 | FORM 4 | 2026-04-15 | View → |
| 4 | FORM 4 | 2026-04-15 | View → |
| DEF 14A | DEF 14A | 2026-04-14 | View → |
| 4 | FORM 4 | 2026-03-23 | View → |
| 4 | FORM 4 | 2026-03-23 | View → |
| 4 | FORM 4 | 2026-03-23 | View → |
| 4 | FORM 4 | 2026-03-16 | View → |
| 4 | FORM 4 | 2026-03-16 | View → |
| 4 | FORM 4 | 2026-03-16 | View → |
| 4 | FORM 4 | 2026-03-16 | View → |
| 4 | FORM 4 | 2026-03-16 | View → |
| 4 | FORM 4 | 2026-03-16 | View → |
| 4 | FORM 4 | 2026-03-16 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $4.27
- Market Cap
- $398.86 million
- 52-Week Range
- $2.74 – $8.59
- Average Volume
- 1.94 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.